Cart (0 Items)
Your cart is currently empty.
View Products
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Tregalizumab Biosimilar - Anti-CD4 mAb - Research Grade |
|---|---|
| Source | CAS 1207446-68-1 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Tregalizumab,BT-061, hB-F5, hBF5(H37L_L4M),CD4,anti-CD4 |
| Reference | PX-TA1263 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Tregalizumab has been investigated for the treatment of Rheumatoid Arthritis.
Immobilized CD4 Protein - T-cell surface glycoprotein CD4(CD4) (cat. No. PX-P4702) at 0.5µg/mL (100µL/well) can bind Tregalizumab Biosimilar - Anti-CD4 mAb (cat. No. PX-TA1263) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 1.099M.
Related products
Send us a message from the form below
Reviews
There are no reviews yet.